Stephen Hoge and Dean Li, at the STAT Summit, spoke of how Merck and Moderna will pair Keytruda with personalized mRNA ...

Pfizer Inc. (NYSE: PFE) will present data from more than 50 company-sponsored, investigator-sponsored and collaborative research abstracts across its infectious disease pipeline and portfolio at the ...

While BNT113 failed to improve progression-free survival in patients with a type of head and neck cancer during a Phase 3 ...

AHEAD-MERIT Phase 2/3 clinical trial did not meet its first dual primary endpoint of progression-free survival for the mRNA cancer immunotherapy candidate BNT113 plus pembrolizumab compared with ...

A brief overview of the careers, tenures and major accomplishments of the CEOs of the top 10 global pharma and biopharma ...

Steady Progress BioNxt’s approach starts with a practical problem: some patients have difficulty swallowing tablets. The Canadian company is therefore developing, among other things, thin films ...

Gov. Tate Reeves has appointed Paul Jerrod “PJ” Waldrop to lead the Mississippi Development Authority. Waldrop will replace retiring Executive Director Bill Cork, effective October 1. Waldrop ...

Pfizer Inc. (NYSE:PFE) and BioNTech SE (NASDAQ:BNTX) announced on August 27 that the U.S. FDA has approved the supplemental Biologics License Application for their 2026–2027 COVID-19 vaccine formula, ...

BioNTech's pipeline setback shouldn't have completely surprised investors. The independent Data Safety Monitoring Board (DSMB) for the Phase 2 study of autogene cevumeran concluded in October 2025 ...

KIRKLAND, QC, Sept. 17, 2026 /CNW/ -- Pfizer Canada ULC and BioNTech SE today announced that Health Canada has authorized the XFG variant-adapted COMIRNATY® for active immunization of individuals aged ...